Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

437
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
437
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer Vaccines01:30

Cancer Vaccines

502
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
502
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same author

The levonorgestrel intrauterine device and ovarian cancer risk: a population-based study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Beyond unopposed estrogen in obesity-associated endometrial cancer risk.

Journal of the National Cancer Institute·2026
Same author

Morbidity, Recurrence and Survival Following Pelvic Exenteration for Gynaecological Malignancies: A Retrospective, Single-Centre Study.

Journal of clinical medicine·2026
Same author

Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressiveness.

Communications medicine·2026
Same author

Uptake of risk-reducing medical interventions among female BRCA1/2 pathogenic variant carriers: A population-based study in British Columbia.

Gynecologic oncology·2026

Related Experiment Video

Updated: Sep 3, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.

Lauren C Tindale1, Almira Zhantuyakova1, Stephanie Lam1

  • 1Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Current Oncology (Toronto, Ont.)
|July 25, 2022
PubMed
Summary
This summary is machine-generated.

Many Canadians with hereditary cancer syndrome (HCS) are unaware of their risk. Population-based genetic testing can improve prevention and save lives by identifying high-risk individuals for early intervention.

Keywords:
BRCAcancer screeninghereditary cancer syndromepopulation-based genetic testing

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K

Related Experiment Videos

Last Updated: Sep 3, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K

Area of Science:

  • Oncology
  • Genetics
  • Public Health

Background:

  • Individuals with hereditary cancer syndromes (HCS), like BRCA1/BRCA2 mutations, face higher risks for ovarian, breast, and other cancers.
  • Early identification of high-risk individuals allows for effective, potentially lifesaving, risk-reducing interventions.
  • A significant gap exists in Canada, with most individuals with HCS unaware of their genetic predisposition.

Purpose of the Study:

  • To explore the potential of population-based genetic testing for hereditary cancer prevention in Canada.
  • To decrease morbidity and mortality associated with gynecologic cancers through proactive genetic screening.
  • To identify research priorities and essential program elements for successful implementation of hereditary cancer prevention strategies.

Main Methods:

  • A research summit, "Gynecologic Cancer Prevention: Thinking Big, Thinking Differently," was convened in Vancouver, Canada.
  • The summit brought together local, national, and international experts to discuss broader implementation of genetic testing in Canada.
  • Key research priorities and essential program components for hereditary cancer prevention were identified.

Main Results:

  • The report summarizes findings from the research summit on hereditary cancer prevention.
  • It describes the current landscape of hereditary genetic programs within the Canadian healthcare system.
  • Incremental steps for immediate prevention improvement and a long-term population-based strategy were outlined.

Conclusions:

  • Implementing population-based genetic testing for hereditary cancer syndrome is crucial for reducing cancer burden in Canada.
  • A coordinated strategy is needed to improve awareness and access to genetic testing and prevention services.
  • Further research and program development are essential to effectively manage hereditary cancer risks in the Canadian population.